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ABsTrACT
Objective Salmonella enterica infections can 
lead to reactive Arthritis (reA), which can exhibit 
an association with human leucocyte antigen 
(HLA)-B*27:05, a molecule prone to misfolding and 
initiation of the unfolded protein response (Upr). this 
study examined how HLA-B*27:05 expression and the 
Upr affect the Salmonella life-cycle within epithelial 
cells.
Methods Isogenic epithelial cell lines expressing 
two copies of either HLA-B*27:05 and a control 
HLA-B*35:01 heavy chain (HC) were generated to 
determine the effect on the Salmonella infection life-
cycle. A cell line expressing HLA-B*27:05.HC physically 
linked to the light chain beta-2-microglobulin and a 
specific peptide (referred to as a single chain trimer, 
SCt) was also generated to determine the effects of 
HLA-B27 folding status on S. enterica life-cycle. xBp-1 
venus and AMp dependent transcription Factor (AtF6)-
FLAG reporters were used to monitor Upr activation 
in infected cells. triacin C was used to inhibit de novo 
lipid synthesis during Upr, and confocal imaging of Er 
tracker stained membrane allowed quantification of 
glibenclamide-associated membrane.
results S. enterica demonstrated enhanced replication 
with an altered cellular localisation in the presence 
of HLA-B*27:05.HC but not in the presence of 
HLA-B*27:05.SCt or HLA-B*35:01. HLA-B*27:05.HC 
altered the threshold for Upr induction. Salmonella 
activated the Upr and required xBp-1 for replication, 
which was associated with endoreticular membrane 
expansion and lipid metabolism.
Conclusions HLA-B27 misfolding and a Upr 
cellular environment are associated with enhanced 
Salmonella replication, while Salmonella itself can 
activate xBp-1 and AtF6. these data provide a potential 
mechanism linking the life-cycle of Salmonella with the 
physicochemical properties of HLA-B27 and cellular 
events that may contribute to reA pathogenesis. our 
observations suggest that the Upr pathway maybe 
targeted for future therapeutic intervention.
InTrOduCTIOn
Misfolding of the human leucocyte antigen B27 
allele (HLA-B27), known to induce the unfolded 
protein response (UPR),1 2 has been proposed to 
explain why HLA-B27 drives the inflammatory 
arthritic disorder ankylosing spondylitis (AS). 
Protein misfolding within the ER can disrupt ER 
homeostasis and trigger the UPR as measured by 
activation of the XBP-12 and ATF6 pathways,1 
and in patients with AS by upregulating the UPR 
effector gene, HRD1.3
The clinical manifestation of Reactive Arthritis 
(ReA) after Salmonella enterica infection has a 
mixed association with HLA-B27.4 Some studies 
suggest that HLA-B27-positive individuals exhibit 
increased susceptibility to ReA5–7 or increased risk 
of Salmonella infection,8 while others have found 
no strong association.9–11 S. enterica grows within a 
specialised membrane-bound compartment termed 
the Salmonella-containing vacuole (SCV) prior to 
cellular escape and dissemination.12–14 The mech-
anistic link between intracellular bacteria and 
HLA-B27 is unknown, but mammalian cell lines 
expressing HLA-B27 can harbour higher numbers 
of internal Salmonella.15–17
We have previously shown that fusing the 
HLA-B27 heavy chain (HC), beta-2-microglob-
ulin (β2m) and presented peptide together within 
a single chain trimer (SCT) significantly reduces 
misfolding relative to the original HC.18 Here 
we have used the SCT to test the hypothesis that 
HLA-B27 misfolding impacts on endocellular 
growth and localisation of S. enterica in infected 
cells. We also tested the extent to which S. enterica 
influences activation of both the XBP-1-and 
ATF6-mediated UPR pathway.
MATerIAls And MeTHOds
uPr induction
UPR responses were induced with tunicamycin 
(TUN), thapsigargin (TPG), MG-132 or calci-
mycin (A23187) from Calbiochem, with appro-
priate vehicle (dimethyl sulfoxide (DMSO) alone) 
controls.
Transfection of uPr reporter constructs
Polyethylenimine (JetPrime) was used to transfect 
cells with the UPR reporter plasmids ΔDBDXBP-1 
venus (v) and ATF6-FLAG19 20 following the manu-
facturer’s conditions. Cells were fixed at the desired 
postinfection (pi) time points for 10 min with 3.8% 
paraformaldehyde (PFA: pH 7.4) and fluorescence 
was measured using LSR2 and LSR Fortessa flow 
cytometers (BD Biosciences), and the data were 
analysed using FlowJo V.8.7.3 software.
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S. enterica cfu enumeration and microscopy
Colony-forming unit (cfu) enumeration was performed by lysing 
cells in 1% Triton X-100/phosphate buffered saline (PBS). Lysates 
were serially diluted into 1% bovine serum albumin/0.1% Tween-
80% and plated on Luria Broth (LB) agar at room temperature 
for ~16 hours. Each experimental condition was performed in 
triplicate and each plating in duplicate. For microscopic analysis, 
coverslips containing infected cells were washed with 1× PBS, 
fixed for 10 min with 3.8% PFA (pH 7.4), washed twice with 1× 
PBS and stored at 4°C.
uPr-mediated membrane expansion during infection
Glibenclamide BODIPY FL (green; Invitrogen) was used to 
quantitate endoreticular membrane size and localisation. Henri-
etta Lacks (HeLa) cells were treated with UPR-inducing drugs 
and labelled with glibenclamide according to the manufactur-
er’s protocol. Labelled cells were analysed by fluorescence acti-
vated cell sorting (FACS). Cell nuclei were counterstained with 
4′,6-diamidino-2-phenylindole (DAPI) and visualised by fluores-
cence microscopy. For control and drug-treated cells, equivalent 
exposures were collected.
To determine endoreticular-derived membrane expansion 
during infection, HeLa cells were grown either on sterile glass, 
infected with S. enterica Typhimurium expressing mCherry 
(see online supplementary materials and methods) and stained 
with glibenclamide green. Cells were fixed, washed and coun-
terstained with DAPI, followed by fluorescence microscopy 
or automated confocal analysis. Images were acquired by an 
Opera LX (PerkinElmer) plate reader with a confocal micro-
scope (NA=0.6, 40× air objective). Exposure times were 100 
ms for the DAPI channel (365 nm), 2000 ms for the ER channel 
(488 nm) and 2000 ms for the Salmonella channel (561 nm). 
Camera pixels were binned by two resulting in a pixel size of 
0.323×0.323 µm, and 4800 images were acquired per 96-well 
plate (50 images per well), which were processed in one batch 
using the same image analysis pipeline, algorithms and param-
eters (see online supplementary materials and methods for 
analysis of glibenclamide mean fluorescence intensity (MFI)).
resulTs
XBP-1 and ATF6 activation following Salmonella infection
We used our previously described epithelial cells with identical 
sites of transgene integration (and therefore isogenic) expressing 
physiological levels of HLA-B273 (online supplementary 
figure S1A–E). Control cell lines encoding HLA-B*35:01 HC 
(HLA-B35.HC) transgene or the FRT vector alone (referred 
to as Empty (E)84) were generated (integration at the same 
two loci). HLA-B27 and HLA-B35.HC lines were incubated 
with or without the influenza nucleoprotein peptide 383–391 
(NP383-391). The ability of HLA-B27 to present cognate peptide 
to NP383-391-specific CD8
+ cytotoxic T lymphocytes (CTL) was 
confirmed by an increase in CD107a cell surface expression 
(online supplementary figure S1F, top right panel). Two-di-
mensional immunoblotting of cell lysates revealed HLA-B27.
HC can form HC-dimers under these experimental conditions 
(figure 1A, arrow top panel), but only monomeric HLA-B35.
HC was detected (figure 1A, bottom panel).
HLA-B27 expression can activate XBP-12 21; therefore, we 
determined whether our cell lines had altered sensitivity to 
UPR induction. Using the XBP-1vΔDBD reporter, which on 
splicing the 26 bp intronic sequences leads to GFP expres-
sion,19 we observed no induction of the UPR within these cell 
lines under normal culture growth conditions. Reasoning the 
expression of HLA-B27 could alter the threshold at which the 
UPR could be activated, we monitored XBP-1vΔDBD activa-
tion with increasing concentrations of the UPR-inducing TPG 
agent. HLA-B27-positive cells had an altered threshold for 
UPR induction, while the E84 and B35 lines did not exhibit 
significant differences (figure 1B).
Next, we determined whether Salmonella affected the UPR 
in the absence of HLA-B27 expression. Cells were infected 
with S. enterica expressing mCherry (referred to as ST.
mCherry), and activation of ΔDBDXBP-1v was monitored 
following various multiplicity of infections, including 3:1, 
50:1 and 100:1 over 1, 4, 8 and 24 hours. XBP-1s activa-
tion was determined by the fold increase in MFI above the 
uninfected ΔDBDXBP-1v transfected cells. Infection led to 
enhanced XBP-1s protein levels 8–24 hours pi (figure 1C). 
Toll like receptors (TLR) ligands LPS and flagellin did not 
activate the ΔDBDXBP-1v reporter and heat-killed bacteria 
had minimal impact (figure 1D). Endogenous XBP-1s mRNA 
levels were then quantified and quantitative (q)PCR of XBP-1s 
transcript levels showed increased expression 8–16 hours pi, 
demonstrating activation of the IRE-1 pathway (figure 1E). We 
also examined the impact of infection on the ATF6 pathway. 
Cells were transfected with ATF6-FLAG, and the cleaved cyto-
solic-FLAG tagged domain was quantified by immunoblot-
ting pi. The peak cleavage of the ATF6 cytosolic domain was 
observed 12 hours pi (figure 1F–G) with a 1.5-fold to 2.5-fold 
increase in activation in infected compared with non-infected 
cells. HeLa.B27.HC-expressing and HeLa.B35.HC-expressing 
cell lines were then tested for their ability to support bacterial 
growth. Cells were infected with S. enterica for 24 hours prior 
to enumeration of cfu. A fourfold to fivefold increase in cfu 
from HLA-B27.HC-expressing cells was observed compared 
with cells expressing HLA-B35.HC or E84 controls (data not 
shown) (figure 1H).
XBP-1 pathway is required for efficient S. enterica 
Typhimurium replication
Our observations suggested that activation of the XBP-1 
pathway plays a significant role in S. enterica growth and 
replication. To support our hypothesis, we analysed S. enterica 
replication in XBP-1-deficient mouse embryonic fibroblasts 
(MEF). XBP-1+/+ and XBP-1−/− MEF cell lines were infected 
with ST.mCherry, harvested and analysed by flow cytom-
etry. Importantly the MFI, which is a measure of the average 
number of bacteria per cell, for both cell types were similar at 
1 and 4 hours pi, indicating no significant differences in either 
bacterial invasion or early infection stages. However, when the 
bacteria began replication, the XBP-1−/− MEF cell line exhib-
ited significantly lower MFI values than the XBP-1+/+ cell line, 
indicating reduced bacterial growth (figure 2A). XBP-1+/+ 
cells had approximately threefold more bacteria than in 
XBP-1−/− cells during the replication phase (8–24 hours pi) 
(figure 2B–C).
enhanced bacterial replication is linked to uPr-induced lipid 
metabolism
Next we wished to test the hypothesis that UPR promotes 
Salmonella replication. To mimic UPR conditions, HeLa cells 
were pretreated with the following UPR-inducing pharmaco-
logical agents: A23187 (0.5 mM), MG132 (0.5 µg/mL), TUN 
(0.5 µg/mL) and TPG (200 nM) (see figure 3A for mode of 
action). HeLa cells were treated with DMSO (vehicle control) 
or the respective UPR inducer 16 hours prior to infection with 
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Figure 1 Salmonella exhibits enhanced replication in the presence of HLA-B27 and can activate XBP-1 and ATF6. (A) Two-dimensional isoelectric 
focusing of lysates from B27.HC cells and immunoblotted with anti-V5 pK demonstrates dimer formation (arrow) (top panel), while B35.HC does not 
form dimers. (B) HLA.B27.HC-expressing cells, transfected with the XBP-1ΔDBDv reporter construct (UPR leads to a 26nt intronic sequence excision, 
leading to the expression of the venus fluorescent protein) and treated with increasing concentrations of TPG exhibit a reduced UPR threshold. (C) 
The fold increase in ΔDBDXBP-1v activation following infection of HeLa cells with ST.mCherry at MOI 3:1, 50:1 and 100:1. (D) The fold increase in 
ΔDBDXBP-1v activation following infection of HeLa cells with ST.mCherry. Non-infected cells (mCherry-negative) from the same well expressing 
ΔDBDXBP-1v were used as non-infected controls to calculate the fold increase in XBP-1 activation in the infected cells (mCherry-positive). No 
induction of XBP-1v activation was seen in cells treated with heat-killed Salmonella enterica Typhimurium (HTST), Lipopolysaccharide (LPS) and 
flagellin (FGN). (E) Activation of endogenous XBP-1s was demonstrated by qPCR. All cycle threshold values were normalised to glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) and data plotted as a fold induction of XBP-1s mRNA compared with levels detected at baseline. (F) The 
fold increase in ATF6 activation as measured by the cleaved cytosolic-FLAG tagged domain, following infection of HeLa cells with ST.mCherry. (G) 
Immunoblot with anti-FLAG tag antibody of AMP dependent transcription factor 6 (ATF6) following infection in two separate experiments (INF1 and 
INF2) compared with non-infected (NI) cells. Inactivated (i) and activated (a) ATF6 are denoted by arrows. For FACS analysis of ΔDBDXBP-1v activation 
(n=3) and densitometry analysis ofATF6 activation (n=3) in infected cells mean values ±SEM are shown and ANOVA was performed (p <0.0001 for 
both figures) with Tukey’smultiple comparison post-test. Significant differences between groups areindicated P< 0.05 (*), P< 0.01 (**) and P< 0.001 
(***) (H) Relative fold increase of bacteria recovered from four individual experiments. Fold increases in Salmonella recovered were calculated based 
on cfu recovered from control E84. There in an average 4.2-fold increase in bacteria recovered from Salmonella-infected HeLa.B27.HC cells relative 
to the E84 and HLA-B35.HC control lines 24 hours post infection. The Mann-Whitney test was used to compare cfu recoveries between HLA-B35-
expressing and HLA-B27-expressing cell lines and the exact p values were calculated (*p=0.0286). ATF6, AMP dependent transcription factor 6;cfu, 
colony-forming unit; E84, empty 84; HC, heavy chain; HeLa, Henrietta Lacks; HLA, human leucocyte antigen; LPS, Lipopolysaccharide; MOI, multiplicity 
of infections; TPG, thapsigargin; UPR, unfolded protein response; v,venus.
ST.mCherry, and the fold increase in infected cells over the 
control was determined 24 hours pi. Overall the data indicate 
that a UPR environment leads to an increase in intracellular 
Salmonella (figure 3B).
TPG appeared to have a more pronounced effect on Salmo-
nella replication and also has the most direct effect on ER 
homeostasis (figure 3A). We employed TPG further to deter-
mine the effect of a pre-existing endoplasmic reticulum (ER) 
stress environment. HeLa cells were treated with TPG at 25, 
100 and 400 nM 16 hours prior to infection. TPG pretreated 
cells showed significant increases in the MFI of infected cells 
when compared with the controls (figure 3C). A fourfold to 
sevenfold increase in TPG-treated cells was recorded 24 hours 
pi (figure 3D). Interestingly, flow cytometry revealed no signif-
icant difference in the percentage of HeLa cells infected with 
increasing TPG concentrations (online supplementary figure 
2). Direct quantification of bacterial replication by cfu recovery 
also demonstrated significant increase in bacterial numbers in 
TPG-treated cells at 8 and 24 hours pi (figure 3E). Depending 
on the signals and duration, UPR can lead to production of 
proapoptotic or antiapoptotic factors. The observed increase 
in bacterial counts 8 hours pi may be due to the production 
of antiapoptotic factors. To assess the level of cell death, acti-
vation of caspases was followed by staining with the fluores-
cein isothiocyanate (FITC) conjugated pan caspase detection 
reagent FLICA and the live dead dye 647. Treatment of cells 
with UPR-inducing drugs did not alter activation of caspases 
or induction of cell death during infection, indicating that the 
observed enhanced bacterial counts post-UPR are not linked to 
increased cellular death (online supplementary figure 3).
Salmonella replication and intracellular niche development 
require a source of membrane, which would depend in part 
on lipid biosynthetic pathways, which can be activated and/
or enhanced by the UPR. We therefore inhibited de novo 
synthesis of long-chain fatty acid synthesis during the induc-
tion of the UPR with Triacin C (TRC), a potent inhibitor of 
long fatty acyl CoA synthetase isoforms 1, 3 and 4. HeLa cells 
were treated with DMSO, TRC (200 nM) and TPG (200 nM) 
or cotreated with TRC (200 nM) and TPG (200 nM) 16 hours 
prior to infection. TRC treatment prior to infection did not 
significantly alter the percentage of cells infected either in 
the presence or absence of TPG (online supplementary figure 
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Figure 2 Salmonella requires an intact XBP-1 pahway for efficient replication. (A) Graph comparing the MFI of infected cells. The MFIs of both cells 
types were similar at early time points (1 and 4 hours pi). When the bacteria enter the log phase replication, the XBP-1−/− cells show much lower MFI 
values than XBP-1+/+ cells. The mean mCherry MFI values±SEM are shown (n=3) and analysis of variance was performed (p<0.0001) with Tukey’s 
multiple comparison post-test to determine if there were significant differences between individual groups (***p<0.001). (B) The fold difference 
in the MFI of the XBP-1+/+/XBP-1−/− cells at the various time points pi. (C) Recovery of viable bacteria from infected cells shows similar differences 
between the XBP-1+/+ and XBP-1−/− cells at 8 and 24 hours pi. The mean fold differences in cfu values (n=5 or 6)±SEM are shown. The MannWhitney 
test was used to compare cfu recoveries.Recoveries between XBP-1+/+ andXBP-1-/- cells and exact p values calculated (* P = 0.015 and ** P=0.031). 
cfu, colony-forming unit; MEFs, mouse embryonic fibroblasts; MFI, mean fluorescence intensity; pi, postinfection.
2). Cells treated with TPG alone showed significant increases 
in MFI values of the infected cells when compared with the 
DMSO or TRC controls (figure 4A). However, cotreatment 
of cells with TRC and TPG significantly reduced the effect of 
the UPR induction on the levels of intracellular bacteria 24 
hours pi (figure 4A,B). These observations were confirmed by 
recovery of viable bacteria from similarly infected HeLa cells 
(figure 4C), indicating inhibition of lipid metabolism during 
UPR induction reduces the increase in intracellular bacteria 
observed at late time points.
Salmonella infection leads to endoreticular membrane 
expansion. To determine whether the increase in intracellular 
bacteria from cells undergoing the UPR was dependent on 
replication within the SCV, we used the isogenic S. enterica 
Typhimurium ΔsifA mutant, which can infect but is impaired 
in intracellular growth and can escape the SCV.22–24 HeLa cells 
were treated with DMSO or 200 nM TPG 16 hours prior to 
infection with ST.mCherry or the isogenic ΔsifA mutant. ST.
mCherry exhibited significant increases after TPG treatment 
as already described. In marked contrast, UPR-induced cells 
infected with the ΔsifA mutant demonstrated no increase in 
bacterial numbers (figure 5A). Thus, intracellular localisation 
within the SCV is required for UPR-mediated effects on bacte-
rial replication.
As UPR activation is associated with endoreticular membrane 
expansion and lipid metabolism,25 26 we determined whether 
Salmonella infection could lead to expansion of endoreticular 
membrane during the replication/growth phase of its life-cycle 
using glibenclamide green ER tracker dye as a marker for 
endoreticular membranes. HeLa cells were infected with either 
wild-type or ΔsifA ST.mCherry as a control strain. At 4 and 
24 hours pi, cells were stained with glibenclamide green ER 
tracker dye and analysed by automated confocal microscopy. 
The levels of glibenclamide-labelled membrane in infected 
cells were quantified and compared with uninfected cells. An 
increase in glibenclamide labelling in cells infected with wild-
type but not sifA-deficient bacteria was observed (figure 5B), 
which supports our observation that XBP-1 is not activated by 
ΔsifA bacteria (data not shown).
The folding status and expression of HlA-B27 alter 
Salmonella replication and cellular localisation
To address the role of the folding status of HLA-B27, we 
generated an HLA-B27 molecule fused to the light chain β2m 
and an HLA-B27-specific peptide derived from the influenza 
nucleoprotein (referred to as HLA-B27.SCT). As a control 
we also generated a similar fusion protein for HLA-B35 with 
EBNA1 peptide (figure 6A). The HLA-B27 and HLA-B35.
SCTs were transfected into the original FLIPIN HeLa founder 
line. Functional activity of the HLA-B27.SCT was determined 
by incubation±NP383-391 peptide. The HLA-B27.SCT line was 
an effective CTL target in the absence (figure 6B, top left 
panel) and presence (figure 6B, top right panel) of exoge-
nously added peptide, whereas the HLA-B35.SCT line did not 
activate HLA-B27-NP-restricted CTL lines (figure 6B, bottom 
left and right panels). We next determined whether HLA-B27.
SCT could form dimeric conformations. Both cell lines were 
treated with N-ethylmaleimide (NEM) and lysates were seper-
ated by charge and Mw as described previously. Immunoblot-
ting with the anti-V5 tag antibody pK revealed that neither 
the HLA-B27 SCT or HLA-B35 SCT lines form high Mw 
conformers (figure 6C, top and bottom panels, respectively).
Next, we wished to know whether HLA-B27.SCT cells could 
support enhanced Salmonella replication. HLA-B27.SCT, along 
with HLA-B35 and B27.HC lines, were infected with ST.Green 
fluorescent protein (GFP). CFU recovery, determined 24 hours 
pi, demonstrated enhanced numbers of bacteria in the B27.HC 
but not in the B27.SCT line (figure 6D).
As Salmonella survival can correlate with their intracellular 
localisation,27 we tracked ST.GFP within the different HLA-class 
I expressing cell lines using confocal microscopy. Following 
infection, cells were costained for the trans-Golgi specific marker 
giantin (red) and the nucleus with DAPI (blue) (figure 6E). 
In the E84 and HLA-B35.HC cell lines, we detected ST.GFP 
concentrated in juxtaposition to the Golgi apparatus, which 
reflects Salmonella within the SCV. Surprisingly, in the presence 
of HLA-B27.HC, we noted that Salmonella markedly do not 
reside in close proximity to the Golgi, but instead was located 
more within the periphery (figure 6F, panel ii). In contrast, in 
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Figure 3 Salmonella exhibits enhanced recovery from cells undergoing UPR. (A) Pharmacological UPR-inducing agents and their mode of action. 
A23187 is a Ca2+ ionophore that disrupts intracellular Ca2+ levels. Thapsigargin is a non-competitive inhibitor of the sarco/endoplasmic reticulum 
Ca2+-ATPase (SERCA) pump leading to reduced Ca2+ endoplasmic reticulum (ER) concentrations. Tunicamycin inhibits the addition of carbohydrate 
(CHO) moities to newly synthesised proteins. MG132 inhibits proteasome-mediated degradation leading to accumulation of misfolded proteins 
within the ER. Triacin C is also shown and inhibits de novo lipid synthesis. (B) Treatment of cells with UPR-inducing drugs increases the number of 
intracellular bacteria 24 hours pi. Cells were treated with A23187 (0.5 mM), MG132 (0.5 µg/mL), TPG (200 nM) and TUN (0.5 µg/mL). The mean fold 
increases in mCherry MFI values±SEM are shown (n=3). ANOVA was performed on mCherry MFI values (p<0.0001) with Tukey’s multiple comparison 
post-test to determine significant differences between individual groups (*p<0.05m, ***p<0.001. (C–D) TPG-treated cells exhibit significant 
increases in MFI values of the infected cells when compared with dimethyl sulfoxide (DMSO) controls (C) and in the fold difference in MFI values 
between the DMSO-treated and TPG-treated cells (D) in a concentration-dependent manner. The mean MFI values±SEM (n=3) are shown and ANOVA 
was performed (p<0.0001) with Tukey’s multiple comparison post-test used to determine if there were significant differences between DMSO and 
all drug-treated groups at 24 hours pi (***p<0.001). (E) Recovery of viable bacteria from infected cells exhibits similar fold differences between the 
DMSO-treated and TPG-treated cells infected at 24 hours pi. The mean fold differences in cfu values (n=6)±SEM are shown. The Mann-Whitney test 
was used to compare cfu recoveries between DMSO-treated and TPG-treated cells and the exact p values were calculated (*p=0.004, **p=0.015). 
ANOVA, analysis of variance; cfu, colony-forming unit; ER, endoplasmic reticulum; MFI, mean fluorescence intensity; pi, postinfection; SERCA, sarco/
endoplasmic reticulum Ca2+-ATPase; TPG, thapsigargin; TUN, tunicamycin; UPR, unfolded protein response.
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Figure 4 Salmonella requires de novo lipid synthesis during enhanced recovery from cells undergoing UPR. (A) HeLa cells were treated with DMSO, 
TRC (200 nM) and TPG (200 nM) or cotreated with 200 nM TRC and 200 nM TPG at 16 hours prior to infection with ST.mCherry. TPG-treated cells 
exhibit significant increases in the MFI values of the infected cells when compared with DMSO or TRC controls. Cotreatment of cells with TRC and 
TPG significantly reduces the effect of the TPG on the levels of intracellular bacteria at 24 hours pi. The mean mCherry MFI values±SEM are shown 
(n=3) and analysis of variance was performed (p<0.0001) with Tukey’s multiple comparison post-test to determine significant differences between 
individual drug treatment groups (***p<0.001). (B) The fold difference in the MFI values of the DMSO, TRC, TPG and TRC/TPG treated cells. (C) 
Observation by FACS was confirmed by recovery of viable bacteria from similarly treated and infected cells. Colonies were counted and the number of 
bacteria present per cell in each sample was calculated (n=12). The Mann-Whitney test was used to compare cfu recoveries between DMSO and TPG 
or TPG and TRC/TPG cotreated cells and the exact p values were calculated (***p=0.0001). cfu, colony-forming unit; DMSO, dimethyl sulfoxide; HeLa, 
Henrietta Lacks; MFI, mean fluorescence intensity; NT, not treated; pi, postinfection; TPG, thapsigargin; TRC, Triacin C; UPR, unfolded protein response.
Figure 5 Salmonella infection can increase endoreticular membranes and exhibit altered cellular location in the presence of HLA-B27. (A) Increase 
in the number of intracellular bacteria in cells treated with UPR-inducing drugs is dependent on the intracellular replication of bacteria within the 
SCV. HeLa cells were treated with DMSO or 200 nM TPG at 16 hours prior to infection with Salmonella enterica Typhimurium 12 023 or ΔsifA strains 
expressing mCherry. Wild-type (WT) bacteria, which replicate within the SCV, show increases in intracellular bacteria in the TPG-treated samples, while 
those infected with the ΔsifA mutant show no increase in the TPG-treated cells. (B) HeLa cells were infected with WT or ΔsifA ST.mCherry, stained 
with ER tracker (green) at 4 and 24 hours pi and analysed by confocal microscopy using an Opera LX plate reader. Quantification of endoreticular 
membrane content in infected cells. MFI of glibenclamide staining in infected (INF) and non-infected (NI) cells were compared at 4 and 24 hours 
pi with either WT or ΔsifA 12023. MFI values±SEM are shown (n=135–1476). For (B) statistical analysis was performed using the Kruskal-Wallis 
test (p<0.0001) and was performed with Dunn’s multiple comparison post-test to determine significant differences between individual groups 
(***p<0.001). DMSO, dimethyl sulfoxide; ER, endoplasmic reticulum; HeLa, Henrietta Lacks; HLA, human leucocyte antigen; MFI, mean fluorescence 
intensity; pi, postinfection; SCV, Salmonella-containing vacuole; TPG, thapsigargin; UPR, unfolded protein response.
infected B27.SCT cells (figure 6F, panel iv), the bacteria resided 
in similar locations to the B35 and E84 cells (figure 6F, panel 
iii), suggesting that bacterial location is associated with enhanced 
replication, in a process influenced by the folding efficiency of 
HLA-B27.
dIsCussIOn
Why Salmonella exhibits an association with ReA and HLA-B27 
remains undetermined. Here we have analysed Salmonella 
growth where HLA-B27 misfolding and the UPR are limiting 
parameters. Our study demonstrates that it is not the expres-
sion of HLA-B27 alone that results in enhanced bacterial repli-
cation, but HLA-B27 misfolding, which influences the ER stress 
environment. Our demonstration that HLA-B27 expression can 
reduce the threshold of ER stress induction and that Salmonella 
can induce the UPR provides key additional insight as to why 
such bacteria manipulate and exploit ER stress pathways to their 
benefit.
In the presence of misfolding HLA-B27, Salmonella predom-
inantly resides in an altered peripheral cellular localisation. 
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Figure 6 Salmonella exhibits altered cellular location in the presence of folding and misfolding HLA-B27. (A) Schematic of the MHC class I SCT 
used in this analysis. (B) HLA-B27.SCT (top left and right panels) can activate NP-specific T cell clones and act as efficient targets in the absence of 
exogenous NP peptide (top left panel). HLA-B35.SCT does not activate NP-B27-specific CTLs (bottom left and right panels). (C) Two-dimensional 
isoelectric focusing of lysates from B27.SCT and B35.SCT cells and immunoblotted with anti-V5 pK demonstrate no dimer formation. (D) Expression 
of HLA-B27 in the context of the SCT molecule reverses the enhanced bacterial recovery phenotype observed in HLA-B27 HC-expressing cells. 
ANOVA was performed (p=0.0033) with Tukey’s multiple comparison post-test to determine significance between individual groups (*,**p<0.05). 
(E) Differences in bacteria recovered at later time points is not due to increased adhesion or invasion of HeLa.B27.HC by ST.GFP. Flow cytometric 
analysis of cells infected with ST.GFP over time shows no observed difference in the number of cells infected or relative number of bacteria per cell 
(as determined by MFI) until later infection time points, that is, >8 hours pi. Data are presented relative to the results from control E84 cells. Two-way 
ANOVA was performed (p<0.0001) with multiple t-tests to determine significance between individual groups (****p<0.0001). (F) Salmonella (green) 
resides in SCVs associated with the Golgi apparatus, stained with giantin (red) in HeLa.FLP (E84, control i) and HeLa.B35.HC (ii). HeLa.B27.SCT-
expressing cells (iv) exhibit no altered localisation of Salmonella when compared with HLA-B27.HC (iii). Arrow heads highlight Salmonella localisation. 
Nuclei are stained with DAPI (blue). ACTL, cytotoxic T lymphocytes; ANOVA, analysis of variance; cfu, colony-forming unit; APC, allophycocyanin; DAPI, 
4′,6-diamidino-2-phenylindole; E84, Empty 84; FLP, flip; GFP, green fluorescent protein; HC, heavy chain; HLA, human leucocyte antigen; MFI, mean 
fluorescence intensity; MHC, major histocompatibility complex; NP, nucleoprotein peptide; PE, phycoerythrin; pi, postinfection; SCT, single chain trimer; 
SCV, Salmonella-containing vacuole.
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Thus HLA-B27 may alter SCV biogenesis and intracellular 
movement. Maturation of the SCV and bacterial cellular local-
isation can determine survival and replicative capability of 
Salmonella.14 22 27 28 During the early stages of infection, the 
SCV migrates by following an endosomal maturation route, to 
a juxtanuclear location associated with the microtubule organ-
ising centre and the Golgi apparatus in epithelial cells.13 14 It is 
possible that the bacteria fail to form an SCV or exit the SCV 
more rapidly in the presence of misfolding HLA-B27, or escape 
from the SCV and randomly redistribute throughout the cyto-
plasm. Alternatively, Salmonella could initially occupy SCVs in 
juxtaposition to the Golgi and the movement to the periphery is 
enhanced in the presence of HLA-B27.
HLA-B27.HC expression and endocellular S. enterica growth 
both independently cause activation of the XBP-1 ER-stress 
pathway. XBP-1 activation peaks at 8–16 hours pi (figure 1D,E), 
which correlates with enhanced bacterial numbers in cells under-
going ER stress and/or expressing HLA-B27.HC with a propen-
sity to misfold. Activation of both XBP-1 and ATF6 coincides 
with the replication/growth phase of S. enterica Typhimurium. 
During this phase Salmonella membrane modifications have 
been reported to be at their peak,29 which might therefore lead to 
UPR activation. We do not currently know the complete cellular 
stress response to Salmonella in our model cell system, but plan 
to address this by RNA-Seq to map other significant differences 
in how HLA-B*27:05-expressing and HLA-B*35:01-expressing 
cells respond after infection. However, taken together, data 
reported here suggest the ER stress consequences of HLA-B27 
misfolding provide a favourable environment for replication of 
S. enterica within the HeLa cells. Interestingly, Salmonella infec-
tions can affect interleukin-23 production,30 a cytokine that has 
been implicated to be important in the disease phenotype of 
spondyloarthropathies.31 It is possible that the co-occurrence of 
Salmonella and HLA-B27 could have a cumulative or multiplica-
tive effect on the UPR, which could explain the enhanced risk of 
ReA and/or an increased risk of symptomatic Salmonella infec-
tion in HLA-B27-positive individuals in a population exposed 
to infection.5 6 8 However, the effects of HLA-B27 on Salmo-
nella may depend on the temporal activation of the UPR.32 Our 
observations with pre-existing UPR activation do suggest that 
these aforementioned factors could indeed influence Salmonella 
replication.
The origin of the membrane that makes up the growing 
SCV remains poorly defined, but ER membrane markers have 
been reported in SCVs. The ER membrane-bound markers 
calnexin and protein disulfide isomerase (PDI) were demon-
strated to codistribute with SCVs and up to 20% of intracellular 
bacteria.33 34 Proteome analysis of host cell membranes modified 
by Salmonella indicated that ER membranes can be redirected 
to their intracellular niche.29 UPR activation can regulate ER 
membrane by increasing phospholipids and ER protein levels, 
as well as modulating fatty acid, sphingolipid, phospholipid 
and sterol metabolism, which ultimately lead to expansion of 
ER membranes.25 26 26 35 36 Our experiments with TRC suggest 
that the long-chain fatty acid CoA synthase (ACSL) family of 
proteins, which are involved in fatty acid degradation, phospho-
lipid remodelling and production of long-chain acyl-CoA esters, 
could well be involved in this pathway.37 38
Several intracellular bacteria such as Brucella and Legionella 
interact directly with ER membrane.39 Recently it has been 
reported that Chlamydia, which is also associated with ReA,40 
can also induce ER stress responses for the purposes of exploiting 
host lipid metabolism.41 Interestingly both Chlamydia and 
Salmonella have been reported to associate with and/or recruit 
ER-derived membranes.29 42 Bacterial species such as Salmonella 
that depend on expansion of membrane compartments to acco-
modate their growth would benefit from the enhanced lipid 
production that results from UPR activation. Together, along 
with observations that HLA-B27 can induce or alter the ER 
stress environment, UPR induction may be a common feature of 
intracellular bacteria that reside in vacuoles and may link with 
the pathology associated with ReA.
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